Beneficial effects of omega-3 fatty acids: The current evidence

Hellenic Journal of Cardiology

Volumn 47, Issue 4, 2006, Pages 223-231

  Gazi, Irene ^a   Liberopoulos, Evangelos N ^a   Saougos, Vasilios G ^a   Elisaf, Moses ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cardiovascular disease; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Hypertriglyceridaemia; Omega 3 fatty acids

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

BLEEDING; BLOOD PRESSURE; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEMENTIA; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; FISHY AFTERTASTE; GASTROINTESTINAL DISEASE; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEMOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; ISCHEMIC HEART DISEASE; REVIEW; SIDE EFFECT; SUPPLEMENTATION; TASTE DISORDER; THROMBOSIS; BLOOD; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; LIPID METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DEMENTIA; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; LIPID METABOLISM; NEOPLASMS; RISK FACTORS;

EID: 35448943894     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel Detection, Evaluation, and Treatment of high blood cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP: Management of high triglycerides: What non-specialists in lipids need to know. Hellenic J Cardiol 2005; 46: 268-272.
3. Assman G, Cullen P, Schulthe H: Simple scoring for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM)) Study. Circulation 2002; 105: 310-315.
4. Gazi I, Liberopoulos E, Mikhailidis DP, et al: Metabolic syndrome: Clinical features leading to therapeutic strategies. Vasc Dis Prevent 2004; 1: 243-253.
5. Kakafika AI, Liberopoulos EN, Karagiannis A, et al: Dyslipidaemia, hypercoagulability and the metabolic syndrome. Curr Vasc Pharmacol 2006, 4: in press
6. Liberopoulos EN, Mikhailidis DP, Elisaf MS: Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283-296.
7. Holub BJ: Clinical Nutrition:4. Omega-3 fatty acids in cardiovascular care. CMAJ 2002; 166: 608-615.
8. Harrison N, Abhyankar B: The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction. Curr Med Res Opin 2005; 21: 95-100.
9. Harris WS: N-3 fatty acids and human lipoprotein metabolism: an update. Lipids 1999; 34(Suppl): S257-258.
10. Harris WS: N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65(Suppl): S1645-S1654
11. Harris WS, Ginsberg HN, Arunakul N, et al: Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4: 385-391.
12. Stalenhoef AFH, de Graaf J, Wittekoek ME, et al: The effect of concentrated fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 2000; 153: 129-138.
13. Balk EM, Lichtenstein AH, Chung M, et al: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, Mar 9: [Epub ahead of print].
14. Seo T, Blaner WS, Deckelbaum RJ: Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr Opin Lipidol 2005; 16: 11-18.
15. Moyad MA: An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part I. Urol Oncol 2005; 23: 28-35.
16. Calder PC: n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004; 107: 1-11.
17. American Heart Association. Heart and Stroke Facts: Statistical Supplement. Dallas, TX: American Heart Association, 1998.
18. DeFilippis AP, Sperling LS: Understanding omega-3's. Am Heart J 2006; 151: 564-570.
19. Bjerregaard P, Dyerberg J: Mortality from ischemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol 1988; 17: 514-519.
20. Newman WP, Middauch JP, Propst MT, et al: Atherosclerosis in Alaska natives and non-natives. Lancet 1993; 341: 1056-1057.
21. Yano K, McLean CJ, Reed DM, et al: A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Am J Epidemiol 1988; 127: 476-487.
22. Bang HO, Dyerberg J, Hjoorne N: The composition of foods consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73.
23. Kris-Etherton PM, Harris WS, Appel LJ, et al, for the Nutrition Committee: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003; 23: e20-e31
24. Harper CR, Jacobson TA: Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005; 96: 1521-1529.
25. Kromhout D: Fish consumption and sudden cardiac death. JAMA 1998; 279: 65-66.
26. Albert CM, Hennekens CH, O'Donnell CJ, et al: Fish consumption and risk of sudden cardiac death. JAMA 1998; 279: 23-28.
27. Sheard NF: Fish consumption and risk of sudden cardiac death. Nutr Rev 1998; 56: 177-179.
28. Marckmann P, Gronbaek M: Fish consumption and coronary heart disease mortality: a systematic review of prospective cohort studies. Eur J Clin Nutr 1999; 53: 585-590.
29. Rissanen T, Voutilainen S, Nyssonen K, et al: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000; 102: 2677-2679.
30. Keli SO, Feskens EJ, Kromhout D: Fish consumption and risk of stroke: the Zutphen study. Stroke 1994; 25: 328-332.
31. Gillum RF, Mussolino ME, Madans JH: The relationship between fish consumption and stroke incidence: the NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey). Arch Intern Med 1996; 156: 537-542.
32. Iso H, Rexrode KM, Stampfer MJ, et al: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001; 285: 304-312.
33. Morris MC, Manson JE, Rosner B, et al: Fish consumption and cardiovascular disease in the Physicians' Health Study: a prospective study. Am J Epidemiol 1995; 142: 166-175.
34. Orencia AJ, Davinglus ML, Dyer AR, et al: Fish consumption and stroke in men: 30-year findings of the Chicago Western Electric Study. Stroke 1996; 27: 204-209.
35. Dietary supplementation with n-3 polyunsaturated fatty acids, vitamin E, after myocardial infarction: results of the GISSI-Prevenzione trial. Grupo Italiano per lo Studio della Sopravivenza nell'Infarto myocardico. Lancet 1999; 354: 447-455.
36. Kromann N, Green A: Epidemiological studies in the Upernavik District, Greenland. Acta Med Scand 1980; 208: 401-406.
37. Burr ML, Fehily AM, Gilbert JF, et al: Effect of changes in fat, fish, and fibre intakes on death and myocardial Reinfarction: Diet And reinfarction trial (DART). Lancet 1989; 2: 757-761.
38. de Lorgeril M, Renaud S, Mamelle N, et al: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-1459.
39. Singh RB, Niaz MA, Sharma JP, et al: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct Survival-4. Cardiovasc Drugs Ther 1997; 11: 485-491.
40. Nilsen DW, Albrektsen G, Landmark K, et al: Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001; 74: 50-56.
41. Burr ML, Ashfield-Watt PA, Dunstan FD, et al: Lack of benefit of dietary advice to men with angina: results of a controlled study. Eur J Clin Nutr 2003; 57: 193-200.
42. Sacks FM, Stone PH, Gibson CM, et al: Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995; 25: 1492-1498.
43. von Schacky C, Angener P, Kothny W, et al: The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 130: 554-562.
44. Bucher HC, Hengstler P, Schindler C, et al: N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304.
45. Studer M, Briel M, Leimenstoll B, et al: Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005; 165: 725-730.
46. Hooper L, Thompson RL, Harrison RA, et al: Risks and benefits of omega 3 fats for mortality, cardiovascular disease and cancer: A systematic review. Br Med J 2006; 332: 752-760.
47. Brunner E: Oily fish and omega 3 fat supplements. Health recommendations conflict with concerns about dwindling supply. Br Med J 2006; 332: 739-740.
48. JELIS (Japan EPA Lipid Intervention Study): Adding fish oil to low-dose statin therapy reduces major coronary events. Presented by Dr Mitsuhiro Yokoyama on November 14th at the American Heart Association Scientific Sessions, Dallas, TX, USA.
49. Harris WS, Connor WE, Alam N, et al: Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. J Lipid Res 1988; 29: 1451-1460.
50. Roche HM, Gibney MJ: Postprandial triacylglycerolaemia: the effect of low-fat dietary treatment with and without fish oil supplementation. Eur J Clin Nutr 1996; 50: 617-624.
51. Lu G, Windsor SL, Harris WS: Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. J Nutr Biochem 1999; 10: 151-158.
52. Chan DC, Watts GF, Mori TA, et al: Randomized control trial of the effect of omega-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr 2003; 77: 300-307.
53. Calabresi L, Donati D, Pazzucconi F, et al: Omacor in familial combined hyperlipidemia: Effects on lipids and low-density lipoprotein subclasses. Atherosclerosis 2000; 148: 387-396.
54. Daviglus ML, Stamler J, Orencia AJ, et al: Fish consumption and 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-1053.
55. Albert CM, Campos H, Stampfer MJ, et al: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-1118.
56. Hu FB, Bronner L, Willett WC, et al: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287: 1815-1821.
57. Mc Lennan PL, Abeywardena MY, Charnock JS: Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 1988; 116: 709-717.
58. McLennan PL: Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 1993; 57: 207-212.
59. Nair SS, Leitch JW, Falconer J, et al: Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997; 127: 383-393.
60. Kang JX, Leaf A: Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation 1996; 94: 1774-1780.
61. Christensen JH, Gustenhoff P, Korup E, et al: Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomized controlled trial. Br Med J 1996; 312: 677-678.
62. Leaf A, Albert CM, Josephson M, et al; Fatty Acid Antiarrhythmia Trial Investigators: Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005; 112: 2762-2768.
63. von Schacky C, Weber PC: Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acid in humans. J Clin Invest 1985; 76: 2446-2450.
64. Ross R: Mechanisms of disease. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
65. Dwyer JH, Allayee H, Dwyer KM, et al: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350: 29-37.
66. Collie-Duguid ES, Wahle KW: Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 1996; 220: 969-974.
67. Hughes DA, Southon S, Pinder AC: N-3 polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996; 126: 603-610.
68. Hughes DA, Pinder AC, Piper Z, et al: Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996; 63: 267-272.
69. Lee TH, Hoover RL, Williams JD, et al: Effects of dietary enrichment with eicosapentaenoic and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217-1224.
70. Sperling RI, Benincaso AI, Knoell CT, et al: Dietary -3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91: 651-660.
71. Baumann KH, Hessel F, Larass I, et al: Dietary -3, -6 and -9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. Arterioscler Thromb Vasc Biol 1999; 19: 59-66.
72. Wallace JMW, Turley E, Gilmore WS, et al: Dietary fish oil supplementation alters leukocyte function and cytokine production in healthy women. Arterioscler Thromb Vasc Biol 1995; 15: 185-189.
73. Endres S, von Schacky C: n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 1996; 7: 48-52.
74. Thies F, Garry GMC, Yaqoob P, et al: Association of polyunsaturated n-3 fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003; 361: 477-485.
75. Rallidis LS, Paschos G, Liakos GK, et al: Dietary a-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167: 237-242.
76. Zampelas A, Paschos G, Rallidis LS, et al: Linoleic acid to alpha-linolenic acid ratio. From clinical trials to inflammatory markers of coronary artery disease. World Rev Nutr Diet 2003; 92: 92-108.
77. Rallidis LS, Paschos G, Papaioannou ML, et al: The effect of diet enriched with a-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 2004; 174: 127-132.
78. Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-533.
79. Appel LJ, Miller ER 3rd, Seidler AJ, et al: Does supplementation of diet with fish oil reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 1429-1438.
80. Mori TA, Watts GF, Burke V, et al: Differential effects of eicosapentaenoic and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000; 102: 1264-1269.
81. Rasmussen BM, Vessby B, Uusitupa M, et al: The KANWU Study Group: Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr 2006; 83: 221-226.
82. Goode GK, Garcia S, Heagerty AM: Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 1997; 96: 2802-2807.
83. Nestel P, Shige H, Pomeroy S, et al: The n-3 fatty acids eicosapentaenoic and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002; 76: 326-330.
84. Chin JPF, Gust A, Nestel PJ, et al: Fish oil dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21: 22-28.
85. Tagawa H, Shimokawa H, Tagawa T, et al: Long term treatment with eicosapentaenoic acid augments both nitric oxidemediated and non-nitric oxide mediated endothelium dependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 1999; 33: 633-640.
86. Harris WS, Rambjor GS, Windsor SL, et al: n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997; 65: 459-464.
87. Morgan DR, Dixon LJ, Hanratty CG, et al: Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 2006; 97: 547-551.
88. MacLean CH, Newberry SJ, Mojica WA, et al: Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006; 295: 403-415.
89. Issa AM, Mojica WA, Morton SC, et al: The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review. Dement Geriatr Cogn Disord 2006; 21: 88-96.
90. US Department of Health and Human Services and US Environmental Protection Agency: FDA and EDA Announce the Revised Consumer Advisory on Methylmercury in Fish. http://www.fda.gov/bbs/topics/news/2004/NEW01038.html. Accessed on November 25th, 2005.